 GATA2 Transcription Factor
"GATA2 Transcription Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An essential GATA transcription factor that is expressed primarily in HEMATOPOIETIC STEM CELLS.
| Descriptor ID |
D050989
|
| MeSH Number(s) |
D12.776.260.235.625 D12.776.260.257.200 D12.776.930.316.625 D12.776.930.321.200
|
| Concept/Terms |
GATA2 Transcription Factor- GATA2 Transcription Factor
- Transcription Factor, GATA2
- NFE1B Erythroid Transcription Factor
- Transcription Factor GATA-2
- GATA-2, Transcription Factor
- Transcription Factor GATA 2
- GATA-Binding Protein 2
- GATA Binding Protein 2
- Nuclear Factor-Erythroid 1B
- Nuclear Factor Erythroid 1B
|
Below are MeSH descriptors whose meaning is more general than "GATA2 Transcription Factor".
Below are MeSH descriptors whose meaning is more specific than "GATA2 Transcription Factor".
This graph shows the total number of publications written about "GATA2 Transcription Factor" by people in UAMS Profiles by year, and whether "GATA2 Transcription Factor" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2025 | 1 | 0 | 1 | | 2023 | 0 | 1 | 1 | | 2021 | 1 | 1 | 2 | | 2014 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "GATA2 Transcription Factor" by people in Profiles over the past ten years.
-
Jabban Y, He R, Bessonen K, Greipp P, Jevremovic D, Foran J, Yi CA, Saliba AN, Hefazi Torghabeh M, Matin A, Hogan W, Mangaonkar A, Patnaik M, Shah M, Alkhateeb H, Al-Kali A. Clinical characteristics and prognostic significance of co-mutated SETBP1/GATA2 myeloid neoplasms. Leuk Res. 2025 Aug; 155:107734.
-
Tenney AP, Di Gioia SA, Webb BD, Chan WM, de Boer E, Garnai SJ, Barry BJ, Ray T, Kosicki M, Robson CD, Zhang Z, Collins TE, Gelber A, Pratt BM, Fujiwara Y, Varshney A, Lek M, Warburton PE, Van Ryzin C, Lehky TJ, Zalewski C, King KA, Brewer CC, Thurm A, Snow J, Facio FM, Narisu N, Bonnycastle LL, Swift A, Chines PS, Bell JL, Mohan S, Whitman MC, Staffieri SE, Elder JE, Demer JL, Torres A, Rachid E, Al-Haddad C, Boustany RM, Mackey DA, Brady AF, Fenollar-Cort?s M, Fradin M, Kleefstra T, Padberg GW, Raskin S, Sato MT, Orkin SH, Parker SCJ, Hadlock TA, Vissers LELM, van Bokhoven H, Jabs EW, Collins FS, Pennacchio LA, Manoli I, Engle EC. Noncoding variants alter GATA2 expression in rhombomere 4 motor neurons and cause dominant hereditary congenital facial paresis. Nat Genet. 2023 07; 55(7):1149-1163.
-
Singh P, Heer M, Resteu A, Mikulasova A, Reza M, Largeaud L, Dufrechou S, Prade N, Dickinson RE, Bustamante J, Neven B, Bigley V, Delabesse E, Rico D, Pasquet M, Collin M. GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1. Blood Adv. 2021 12 28; 5(24):5631-5635.
-
Nanaa A, Viswanatha D, Xie Z, Jevremovic D, Nguyen P, Salama ME, Greipp P, Bessonen K, Gangat N, Patnaik M, Pardanani A, Alkhateeb HB, Shah M, Hogan W, Tefferi A, Litzow M, He R, Al-Kali A. Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience. Blood Cancer J. 2021 06 30; 11(6):122.
|
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|